Alliancebernstein L.P. Blueprint Medicines Corp Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 1,217,705 shares of BPMC stock, worth $134 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,217,705

Previous 1,139,002 6.91%

Holding current value

$134 Million

Previous $123 Million 8.29%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$84.1 - $120.5 $6.62 Million - $9.48 Million	78,703 Added 6.91%	1,217,705 $113 Million
Q2 2024 Aug 14, 2024	SELL	$85.18 - $108.78 $5.5 Million - $7.03 Million	-64,590 Reduced 5.37%	1,139,002 $123 Million
Q1 2024 May 14, 2024	SELL	$73.17 - $99.79 $11.3 Million - $15.4 Million	-154,391 Reduced 11.37%	1,203,592 $114 Million
Q4 2023 Feb 14, 2024	SELL	$43.96 - $92.84 $6.12 Million - $12.9 Million	-139,271 Reduced 9.3%	1,357,983 $125 Million
Q3 2023 Nov 14, 2023	SELL	$46.9 - $66.0 $5.34 Million - $7.52 Million	-113,927 Reduced 7.07%	1,497,254 $75.2 Million
Q2 2023 Aug 15, 2023	SELL	$42.2 - $66.37 $5.51 Million - $8.67 Million	-130,623 Reduced 7.5%	1,611,181 $102 Million
Q1 2023 May 15, 2023	BUY	$37.97 - $50.0 $7.81 Million - $10.3 Million	205,649 Added 13.39%	1,741,804 $78.4 Million
Q4 2022 Feb 14, 2023	BUY	$41.06 - $66.48 $5.22 Million - $8.45 Million	127,048 Added 9.02%	1,536,155 $67.3 Million
Q3 2022 Nov 15, 2022	SELL	$49.93 - $77.7 $4.41 Million - $6.86 Million	-88,298 Reduced 5.9%	1,409,107 $92.8 Million
Q2 2022 Aug 15, 2022	SELL	$45.23 - $70.15 $614,494 - $953,057	-13,586 Reduced 0.9%	1,497,405 $75.6 Million
Q1 2022 May 13, 2022	BUY	$54.1 - $110.08 $554,308 - $1.13 Million	10,246 Added 0.68%	1,510,991 $96.5 Million
Q4 2021 Feb 14, 2022	BUY	$94.25 - $115.99 $10 Million - $12.4 Million	106,541 Added 7.64%	1,500,745 $161 Million
Q3 2021 Nov 10, 2021	SELL	$80.98 - $109.47 $650,674 - $879,591	-8,035 Reduced 0.57%	1,394,204 $143 Million
Q2 2021 Jul 30, 2021	BUY	$82.78 - $101.0 $237,578 - $289,870	2,870 Added 0.21%	1,402,239 $123 Million
Q1 2021 May 06, 2021	BUY	$90.71 - $108.28 $10 Million - $12 Million	110,564 Added 8.58%	1,399,369 $136 Million
Q4 2020 Feb 08, 2021	SELL	$92.08 - $124.48 $3.13 Million - $4.23 Million	-34,008 Reduced 2.57%	1,288,805 $145 Million
Q3 2020 Nov 12, 2020	BUY	$66.45 - $92.7 $10.1 Million - $14.1 Million	151,989 Added 12.98%	1,322,813 $123 Million
Q2 2020 Aug 13, 2020	BUY	$57.09 - $79.27 $4.88 Million - $6.78 Million	85,477 Added 7.88%	1,170,824 $91.3 Million
Q1 2020 May 14, 2020	SELL	$48.11 - $82.22 $1.88 Million - $3.22 Million	-39,126 Reduced 3.48%	1,085,347 $63.5 Million
Q4 2019 Feb 18, 2020	BUY	$66.73 - $82.59 $4.13 Million - $5.12 Million	61,955 Added 5.83%	1,124,473 $90.1 Million
Q3 2019 Nov 14, 2019	BUY	$72.9 - $101.41 $1.54 Million - $2.14 Million	21,148 Added 2.03%	1,062,518 $78.1 Million
Q2 2019 Aug 14, 2019	BUY	$73.54 - $97.8 $3.62 Million - $4.82 Million	49,241 Added 4.96%	1,041,370 $98.2 Million
Q1 2019 May 14, 2019	BUY	$48.7 - $86.6 $6 Million - $10.7 Million	123,259 Added 14.19%	992,129 $79.4 Million
Q4 2018 Feb 13, 2019	SELL	$45.57 - $74.26 $7.2 Million - $11.7 Million	-157,952 Reduced 15.38%	868,870 $46.8 Million
Q3 2018 Nov 08, 2018	BUY	$58.91 - $78.32 $14.8 Million - $19.7 Million	252,028 Added 32.53%	1,026,822 $80.2 Million
Q2 2018 Aug 13, 2018	SELL	$60.96 - $101.18 $1.93 Million - $3.21 Million	-31,733 Reduced 3.93%	774,794 $49.2 Million
Q1 2018 May 14, 2018	SELL	$73.28 - $102.95 $4.63 Million - $6.51 Million	-63,240 Reduced 7.27%	806,527 $74 Million
Q4 2017 Feb 13, 2018	SELL	$62.91 - $88.32 $12.9 Million - $18 Million	-204,296 Reduced 19.02%	869,767 $65.6 Million
Q3 2017 Nov 13, 2017	BUY	$42.37 - $69.67 $45.5 Million - $74.8 Million	1,074,063	1,074,063 $74.8 Million

Others Institutions Holding BPMC

# of Institutions

350

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $6.57B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Blueprint Medicines Corp Transaction History